NASDAQ · Financial Statements
TRex Bio Inc. (TRXB) Revenue, Earnings & Financial Statements
$11.83
NASDAQ: TRXB
Market Cap $98.54M
Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
TRex Bio Inc. most recently reported annual revenue of $0, a net loss of $35.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Income Statement — 1 Years (USD millions)
Quarterly Results — Last 3 Quarters (USD millions)
Balance Sheet — 1 Years (USD millions)
Cash Flow Statement — 1 Years (USD millions)
TRex Bio Inc. (TRXB) financials — frequently asked questions
What is TRex Bio Inc.'s annual revenue?
TRex Bio Inc. (TRXB) reported annual revenue of $0 in its most recent fiscal year.
What is TRex Bio Inc.'s net profit?
TRex Bio Inc. (TRXB) reported a net loss of $35.0M in its most recent fiscal year.
Revenue and earnings of other Medical - Pharmaceuticals stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.